Filing Details
- Accession Number:
- 0001104659-22-066221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-31 07:13:23
- Reporting Period:
- 2022-05-27
- Accepted Time:
- 2022-05-31 07:13:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1012477 | Avadel Pharmaceuticals Plc | AVDL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1410677 | J Gregory Divis | C/O Avadel Pharmaceuticals Plc 10 Earlsfort Terrace Dublin 2 L2 D02 T380 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Adss | Acquisiton | 2022-05-27 | 50,000 | $2.05 | 149,100 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.